Clinical Trials Browser

Phase 2 × Urinary Bladder Neoplasms × rubitecan × Clear all

NCT00006026 2012-09-24

Nitrocamptothecin in Treating Patients With Metastatic Cancer of the Urinary Tract

Phase 2 Completed

Urinary Bladder Neoplasms, Urethral Neoplasms